Literature DB >> 12082608

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

Michele Albertoni1, Phillip H Shaw, Michimasa Nozaki, Sophie Godard, Mirna Tenan, Marie-France Hamou, Douglas W Fairlie, Samuel N Breit, Vishwas M Paralkar, Nicolas de Tribolet, Erwin G Van Meir, Monika E Hegi.   

Abstract

Human astrocytic brain tumors select for mutations in the p53 tumor suppressor gene early in malignant progression. p53 is activated upon various kinds of cellular stress leading to apoptosis or cell cycle arrest, but is also implicated in complex biological processes such as inhibition of angiogenesis and metastasis. In an effort to shed light on consequences mediated by p53 inactivation in gliomas, we established the Tet-On system for p53 in the LN-Z308 glioblastoma cell line. The macrophage inhibitory cytokine-1 (MIC-1) gene was identified as a most prominent p53 target gene upon gene expression profiling. Oxygen deprivation, an important cellular stress, revealed MIC-1 as an anoxia responsive gene in glioblastoma cell lines. MIC-1 up-regulation by anoxia is mediated through an alternative, p53 and hypoxia inducible factor 1 (HIF-1) independent pathway. Furthermore, ectopic expression of MIC-1 in LN-Z308 cell line completely abolished its inherent tumorigenicity in nude mice, while proliferation in vitro was not affected. In the present experimental model MIC-1 may exert its anti-tumorigenic properties via a paracrine mechanism mediated by host cells in vivo. Taken together, these data suggest that MIC-1 is an important downstream mediator of p53 function, while acting itself as an intercessor of cellular stress signaling and exerting anti-tumorigenic activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082608     DOI: 10.1038/sj.onc.1205610

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

1.  Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?

Authors:  David A Brown; Kenneth W Hance; Connie J Rogers; Leah B Sansbury; Paul S Albert; Gwen Murphy; Adeyinka O Laiyemo; Zhuoqiao Wang; Amanda J Cross; Arthur Schatzkin; Mark Danta; Preeyaporn Srasuebkul; Janaki Amin; Matthew Law; Samuel N Breit; Elaine Lanza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

Review 2.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

3.  DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation.

Authors:  Kedar Hastak; Rajib K Paul; Mukesh K Agarwal; Vijay S Thakur; A R M Ruhul Amin; Sudesh Agrawal; R Michael Sramkoski; James W Jacobberger; Mark W Jackson; George R Stark; Munna L Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

4.  Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.

Authors:  Fengting Yan; Lapo Alinari; Mark E Lustberg; Ludmila Katherine Martin; Hector M Cordero-Nieves; Yeshavanth Banasavadi-Siddegowda; Selene Virk; Jill Barnholtz-Sloan; Erica Hlavin Bell; Jeffrey Wojton; Naduparambil K Jacob; Arnab Chakravarti; Michal O Nowicki; Xin Wu; Rosa Lapalombella; Jharna Datta; Bo Yu; Kate Gordon; Amy Haseley; John T Patton; Porsha L Smith; John Ryu; Xiaoli Zhang; Xiaokui Mo; Guido Marcucci; Gerard Nuovo; Chang-Hyuk Kwon; John C Byrd; E Antonio Chiocca; Chenglong Li; Said Sif; Samson Jacob; Sean Lawler; Balveen Kaur; Robert A Baiocchi
Journal:  Cancer Res       Date:  2014-01-22       Impact factor: 12.701

5.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

6.  DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

Authors:  Katrin Friedrich; Jan Rh Hanauer; Steffen Prüfer; Robert C Münch; Iris Völker; Christodoulos Filippis; Christian Jost; Kay-Martin Hanschmann; Roberto Cattaneo; Kah-Whye Peng; Andreas Plückthun; Christian J Buchholz; Klaus Cichutek; Michael D Mühlebach
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

7.  Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms.

Authors:  Mikkel Rohde; Mads Daugaard; Mette Hartvig Jensen; Kristian Helin; Jesper Nylandsted; Marja Jäättelä
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

8.  Induction of MIC-1/growth differentiation factor-15 following bile duct injury.

Authors:  Leonidas G Koniaris
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

Review 9.  The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer.

Authors:  Xingya Wang; Seung Joon Baek; Thomas E Eling
Journal:  Biochem Pharmacol       Date:  2012-12-07       Impact factor: 5.858

10.  Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.

Authors:  R J E Skipworth; D A C Deans; B H L Tan; K Sangster; S Paterson-Brown; D A Brown; M Hunter; S N Breit; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.